Eli Lilly Message Board - Msg: 32823659

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Eli Lilly

LLY 1,065

+2.2%

2:07 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Moonray	7/8/2020 8:07:04 AM
	of 642

The key takeaway It is worth noting that Eli Lilly's lineup goes beyond its diabetes products. For instance, the company's immunosuppressant Taltz and cancer treatments Alimta and Cyramza have strong and growing sales. Eli Lilly also has a pipeline of more than two dozen products from which it can continuously replenish its lineup . Thanks to all these factors, I think Eli Lilly is pos- itioned to continue delivering strong financial results. Its stock will likely go on outperforming the market in the long run. In short, I think Eli Lilly is a pharma stock worth buying today. More at: 3 Reasons to Buy Eli Lilly Stock o~~~ O

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next